文献速递生殖医学

既往单侧卵巢切除妇女体外受精/卵胞浆内单精子注射后的活产率与妊娠率:系统综述与Meta分析

Live birth and pregnancy rates after in vitro fertilization/intracytoplasmic sperm injection in women with previous unilateral oophorectomy: a systematic review and meta-analysis.
PubMed 文献 · Fertil Steril · 2022-03-08

该系统综述与Meta分析纳入18项观察性研究,比较既往单侧卵巢切除(UO)妇女与对照的体外受精/卵胞浆内单精子注射(IVF/ICSI)结局,分析队列含UO组1,057个周期、对照组45,813个周期。UO组活产OR=0.72(95%CI 0.57-0.91,z=-2.72)、每启动周期妊娠OR=0.70(95%CI 0.57-0.86,z=-3.35),促性腺激素用量更高、获卵数更低。

要点

  • 既往UO妇女IVF/ICSI活产OR=0.72(95%CI 0.57-0.91,z=-2.72),低于对照。
  • 每启动周期妊娠OR=0.70(95%CI 0.57-0.86,z=-3.35),低于对照。
  • UO组促性腺激素用量显著更高,获卵数显著更低。

核心结论

  • Meta分析显示既往UO对IVF/ICSI活产率和妊娠率有显著不利影响。
  • 分析进一步支持既往数据:既往UO妇女对促性腺激素敏感性降低、获卵数减少。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE、Embase、Web of Science及引用文献,纳入截至2021年6月1日发表的18项研究。
  • 最终分析队列含既往UO妇女1,057个IVF/ICSI周期和对照妇女45,813个IVF/ICSI周期。
  • 研究质量按纽卡斯尔-渥太华质量评估量表评为中至高质量(5至8分),所有研究均为观察性研究。
  • 研究注册号:PROSPERO 2020,CRD42020160313。

主要发现

  • 既往UO组活产OR=0.72(95%CI 0.57-0.91,z=-2.72),显著低于对照。
  • 既往UO组每启动治疗周期妊娠率OR=0.70(95%CI 0.57-0.86,z=-3.35),显著低于对照。
  • 既往UO组促性腺激素给药剂量显著更高,获卵数显著更低。

关键数值与推荐

  • 主要结局为IVF/ICSI后活产率和妊娠率,次要结局包括卵巢刺激促性腺激素用量和获卵数。
  • 活产OR=0.72(95%CI 0.57-0.91,z=-2.72),妊娠OR=0.70(95%CI 0.57-0.86,z=-3.35)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 所有研究均为观察性研究,存在固有偏倚,异质性高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To quantify the effect of unilateral oophorectomy (UO) on the rates of live birth and pregnancy in women undergoing in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI). DESIGN: Systematic review and meta-analysis. SETTING: Search of databases of published articles. PATIENT(S): The final analytical cohort encompassed 1,057 IVF/ICSI cycles in women with previous UO and 45,813 IVF/ICSI cycles in control women. Eighteen studies were identified by database searches of MEDLINE, Embase, Web of Science, and cited references. The review encompassed studies published up to June 1, 2021. INTERVENTION(S): UO prior to IVF/ICSI. MAIN OUTCOME MEASURE(S): The primary outcomes were the rates of live birth and pregnancy following IVF/ICSI. The secondary outcomes included the amount of gonadotropins administered for ovarian stimulation and the number of retrieved oocytes. RESULT(S): The studies were rated from medium to high quality (from 5 to 8) according to the Newcastle-Ottawa Quality Assessment Scale. All studies were observational, with inherent bias, and heterogeneity was high. The primary outcome of live birth had a significantly lower odds ratio (OR) in women with previous UO compared with controls (OR = 0.72, 95% confidence interval [CI] 0.57 to 0.91, z = -2.72). The OR for pregnancy rate per initiated treatment cycle was also significantly lower in women with previous UO compared with controls (OR = 0.70, 95% CI 0.57 to 0.86, z = -3.35). Additionally, the dose of administered gonadotropins was significantly higher and the number of retrieved oocytes was significantly lower in women with UO. CONCLUSION(S): The meta-analysis showed a significant detrimental effect of UO on the rates of live birth and pregnancy. The analysis further supports previous data showing a decreased sensitivity to gonadotropins and a lower number of recovered oocytes in women with previous UO. STUDY REGISTRATION NUMBER: PROSPERO 2020, CRD42020160313.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Rodriguez-Wallberg KA, Nilsson HP, Lind T, et al. Live birth and pregnancy rates after in vitro fertilization/intracytoplasmic sperm injection in women with previous unilateral oophorectomy: a systematic review and meta-analysis. Fertil Steril. 2022. PMID: 35277262. doi:10.1016/j.fertnstert.2022.01.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。